WP1066 is a JAK-2 kinase inhibitor that blocks STAT3 tyrosine phosphorylation, and has proapoptotic and antiproliferative activity in a variety of cancers, including glioma [21, 50]. The gene discussed is STAT3; the disease is central nervous system cancer.